ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Gene Sequencers Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-8R17677
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Targeted Gene Sequencers Market Research Report 2024
BUY CHAPTERS

Global Targeted Gene Sequencers Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-8R17677
Report
October 2025
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pacific Biosciences
Oxford Nanopore Technologies
Element Biosciences
Roche
MGI Tech
GeneMind

Targeted Gene Sequencers Market

The global Targeted Gene Sequencers market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Scientific Research accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Targeted Gene Sequencers leading manufacturers including Thermo Fisher Scientific, Illumina, Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences, Roche, Mgi Tech, GeneMind, etc., dominate supply; the top five capture approximately % of global revenue, with Thermo Fisher Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Targeted Gene Sequencers market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Targeted Gene Sequencers Market Report

Report Metric Details
Report Name Targeted Gene Sequencers Market
Segment by Type
  • Single Carrier
  • Multi-Carrier
Segment by Application
  • Scientific Research
  • Clinical Medicine
  • Agriculture
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Illumina, Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences, Roche, Mgi Tech, GeneMind
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Targeted Gene Sequencers study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Targeted Gene Sequencers Market report?

Ans: The main players in the Targeted Gene Sequencers Market are Thermo Fisher Scientific, Illumina, Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences, Roche, Mgi Tech, GeneMind

What are the Application segmentation covered in the Targeted Gene Sequencers Market report?

Ans: The Applications covered in the Targeted Gene Sequencers Market report are Scientific Research, Clinical Medicine, Agriculture, Others

What are the Type segmentation covered in the Targeted Gene Sequencers Market report?

Ans: The Types covered in the Targeted Gene Sequencers Market report are Single Carrier, Multi-Carrier

1 Study Coverage
1.1 Introduction to Targeted Gene Sequencers: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Targeted Gene Sequencers Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single Carrier
1.2.3 Multi-Carrier
1.3 Market Segmentation by Application
1.3.1 Global Targeted Gene Sequencers Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Scientific Research
1.3.3 Clinical Medicine
1.3.4 Agriculture
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Targeted Gene Sequencers Revenue Estimates and Forecasts 2020-2031
2.2 Global Targeted Gene Sequencers Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Targeted Gene Sequencers Sales Estimates and Forecasts 2020-2031
2.4 Global Targeted Gene Sequencers Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Targeted Gene Sequencers Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Targeted Gene Sequencers Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Single Carrier Market Size by Manufacturers
3.5.2 Multi-Carrier Market Size by Manufacturers
3.6 Global Targeted Gene Sequencers Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Targeted Gene Sequencers Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Targeted Gene Sequencers Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Targeted Gene Sequencers Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Targeted Gene Sequencers Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Targeted Gene Sequencers Sales and Revenue by Type (2020-2031)
6.4 North America Targeted Gene Sequencers Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Targeted Gene Sequencers Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Targeted Gene Sequencers Sales and Revenue by Type (2020-2031)
7.4 Europe Targeted Gene Sequencers Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Targeted Gene Sequencers Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Targeted Gene Sequencers Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Targeted Gene Sequencers Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Targeted Gene Sequencers Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Targeted Gene Sequencers Sales and Revenue by Type (2020-2031)
9.4 Central and South America Targeted Gene Sequencers Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Targeted Gene Sequencers Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Targeted Gene Sequencers Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Targeted Gene Sequencers Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Targeted Gene Sequencers Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Targeted Gene Sequencers Product Models, Descriptions and Specifications
11.1.4 Thermo Fisher Scientific Targeted Gene Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Targeted Gene Sequencers Sales by Product in 2024
11.1.6 Thermo Fisher Scientific Targeted Gene Sequencers Sales by Application in 2024
11.1.7 Thermo Fisher Scientific Targeted Gene Sequencers Sales by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Targeted Gene Sequencers SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 Illumina
11.2.1 Illumina Corporation Information
11.2.2 Illumina Business Overview
11.2.3 Illumina Targeted Gene Sequencers Product Models, Descriptions and Specifications
11.2.4 Illumina Targeted Gene Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Illumina Targeted Gene Sequencers Sales by Product in 2024
11.2.6 Illumina Targeted Gene Sequencers Sales by Application in 2024
11.2.7 Illumina Targeted Gene Sequencers Sales by Geographic Area in 2024
11.2.8 Illumina Targeted Gene Sequencers SWOT Analysis
11.2.9 Illumina Recent Developments
11.3 Pacific Biosciences
11.3.1 Pacific Biosciences Corporation Information
11.3.2 Pacific Biosciences Business Overview
11.3.3 Pacific Biosciences Targeted Gene Sequencers Product Models, Descriptions and Specifications
11.3.4 Pacific Biosciences Targeted Gene Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Pacific Biosciences Targeted Gene Sequencers Sales by Product in 2024
11.3.6 Pacific Biosciences Targeted Gene Sequencers Sales by Application in 2024
11.3.7 Pacific Biosciences Targeted Gene Sequencers Sales by Geographic Area in 2024
11.3.8 Pacific Biosciences Targeted Gene Sequencers SWOT Analysis
11.3.9 Pacific Biosciences Recent Developments
11.4 Oxford Nanopore Technologies
11.4.1 Oxford Nanopore Technologies Corporation Information
11.4.2 Oxford Nanopore Technologies Business Overview
11.4.3 Oxford Nanopore Technologies Targeted Gene Sequencers Product Models, Descriptions and Specifications
11.4.4 Oxford Nanopore Technologies Targeted Gene Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Oxford Nanopore Technologies Targeted Gene Sequencers Sales by Product in 2024
11.4.6 Oxford Nanopore Technologies Targeted Gene Sequencers Sales by Application in 2024
11.4.7 Oxford Nanopore Technologies Targeted Gene Sequencers Sales by Geographic Area in 2024
11.4.8 Oxford Nanopore Technologies Targeted Gene Sequencers SWOT Analysis
11.4.9 Oxford Nanopore Technologies Recent Developments
11.5 Element Biosciences
11.5.1 Element Biosciences Corporation Information
11.5.2 Element Biosciences Business Overview
11.5.3 Element Biosciences Targeted Gene Sequencers Product Models, Descriptions and Specifications
11.5.4 Element Biosciences Targeted Gene Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Element Biosciences Targeted Gene Sequencers Sales by Product in 2024
11.5.6 Element Biosciences Targeted Gene Sequencers Sales by Application in 2024
11.5.7 Element Biosciences Targeted Gene Sequencers Sales by Geographic Area in 2024
11.5.8 Element Biosciences Targeted Gene Sequencers SWOT Analysis
11.5.9 Element Biosciences Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Business Overview
11.6.3 Roche Targeted Gene Sequencers Product Models, Descriptions and Specifications
11.6.4 Roche Targeted Gene Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Roche Recent Developments
11.7 Mgi Tech
11.7.1 Mgi Tech Corporation Information
11.7.2 Mgi Tech Business Overview
11.7.3 Mgi Tech Targeted Gene Sequencers Product Models, Descriptions and Specifications
11.7.4 Mgi Tech Targeted Gene Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Mgi Tech Recent Developments
11.8 GeneMind
11.8.1 GeneMind Corporation Information
11.8.2 GeneMind Business Overview
11.8.3 GeneMind Targeted Gene Sequencers Product Models, Descriptions and Specifications
11.8.4 GeneMind Targeted Gene Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 GeneMind Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Targeted Gene Sequencers Industry Chain
12.2 Targeted Gene Sequencers Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Targeted Gene Sequencers Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Targeted Gene Sequencers Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Targeted Gene Sequencers Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Targeted Gene Sequencers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Pacific Biosciences
Oxford Nanopore Technologies
Element Biosciences
Roche
MGI Tech
GeneMind
List of Tables
 Table 1. Global Targeted Gene Sequencers Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Targeted Gene Sequencers Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Targeted Gene Sequencers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Targeted Gene Sequencers Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Targeted Gene Sequencers Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Targeted Gene Sequencers Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Targeted Gene Sequencers Sales by Region (2020-2025) & (Units)
 Table 8. Global Targeted Gene Sequencers Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Targeted Gene Sequencers Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Targeted Gene Sequencers Sales Share by Manufacturers (2020-2025)
 Table 12. Global Targeted Gene Sequencers Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Targeted Gene Sequencers Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Targeted Gene Sequencers by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Gene Sequencers as of 2024)
 Table 16. Global Targeted Gene Sequencers Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Targeted Gene Sequencers Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
 Table 18. Key Manufacturers Targeted Gene Sequencers Manufacturing Base and Headquarters
 Table 19. Global Targeted Gene Sequencers Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Targeted Gene Sequencers Sales by Type (2020-2025) & (Units)
 Table 23. Global Targeted Gene Sequencers Sales by Type (2026-2031) & (Units)
 Table 24. Global Targeted Gene Sequencers Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Targeted Gene Sequencers Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Targeted Gene Sequencers ASP by Type (2020-2031) & (K US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Targeted Gene Sequencers Sales by Application (2020-2025) & (Units)
 Table 29. Global Targeted Gene Sequencers Sales by Application (2026-2031) & (Units)
 Table 30. Targeted Gene Sequencers High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Targeted Gene Sequencers Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Targeted Gene Sequencers Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Targeted Gene Sequencers ASP by Application (2020-2031) & (K US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Targeted Gene Sequencers Growth Accelerators and Market Barriers
 Table 37. North America Targeted Gene Sequencers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Targeted Gene Sequencers Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Targeted Gene Sequencers Growth Accelerators and Market Barriers
 Table 40. Europe Targeted Gene Sequencers Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Targeted Gene Sequencers Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Targeted Gene Sequencers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Targeted Gene Sequencers Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Targeted Gene Sequencers Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Targeted Gene Sequencers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Targeted Gene Sequencers Investment Opportunities and Key Challenges
 Table 47. Central and South America Targeted Gene Sequencers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Targeted Gene Sequencers Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Targeted Gene Sequencers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Thermo Fisher Scientific Corporation Information
 Table 51. Thermo Fisher Scientific Description and Major Businesses
 Table 52. Thermo Fisher Scientific Product Models, Descriptions and Specifications
 Table 53. Thermo Fisher Scientific Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 54. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
 Table 55. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
 Table 56. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
 Table 57. Thermo Fisher Scientific Targeted Gene Sequencers SWOT Analysis
 Table 58. Thermo Fisher Scientific Recent Developments
 Table 59. Illumina Corporation Information
 Table 60. Illumina Description and Major Businesses
 Table 61. Illumina Product Models, Descriptions and Specifications
 Table 62. Illumina Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 63. Illumina Sales Value Proportion by Product in 2024
 Table 64. Illumina Sales Value Proportion by Application in 2024
 Table 65. Illumina Sales Value Proportion by Geographic Area in 2024
 Table 66. Illumina Targeted Gene Sequencers SWOT Analysis
 Table 67. Illumina Recent Developments
 Table 68. Pacific Biosciences Corporation Information
 Table 69. Pacific Biosciences Description and Major Businesses
 Table 70. Pacific Biosciences Product Models, Descriptions and Specifications
 Table 71. Pacific Biosciences Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 72. Pacific Biosciences Sales Value Proportion by Product in 2024
 Table 73. Pacific Biosciences Sales Value Proportion by Application in 2024
 Table 74. Pacific Biosciences Sales Value Proportion by Geographic Area in 2024
 Table 75. Pacific Biosciences Targeted Gene Sequencers SWOT Analysis
 Table 76. Pacific Biosciences Recent Developments
 Table 77. Oxford Nanopore Technologies Corporation Information
 Table 78. Oxford Nanopore Technologies Description and Major Businesses
 Table 79. Oxford Nanopore Technologies Product Models, Descriptions and Specifications
 Table 80. Oxford Nanopore Technologies Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 81. Oxford Nanopore Technologies Sales Value Proportion by Product in 2024
 Table 82. Oxford Nanopore Technologies Sales Value Proportion by Application in 2024
 Table 83. Oxford Nanopore Technologies Sales Value Proportion by Geographic Area in 2024
 Table 84. Oxford Nanopore Technologies Targeted Gene Sequencers SWOT Analysis
 Table 85. Oxford Nanopore Technologies Recent Developments
 Table 86. Element Biosciences Corporation Information
 Table 87. Element Biosciences Description and Major Businesses
 Table 88. Element Biosciences Product Models, Descriptions and Specifications
 Table 89. Element Biosciences Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 90. Element Biosciences Sales Value Proportion by Product in 2024
 Table 91. Element Biosciences Sales Value Proportion by Application in 2024
 Table 92. Element Biosciences Sales Value Proportion by Geographic Area in 2024
 Table 93. Element Biosciences Targeted Gene Sequencers SWOT Analysis
 Table 94. Element Biosciences Recent Developments
 Table 95. Roche Corporation Information
 Table 96. Roche Description and Major Businesses
 Table 97. Roche Product Models, Descriptions and Specifications
 Table 98. Roche Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 99. Roche Recent Developments
 Table 100. Mgi Tech Corporation Information
 Table 101. Mgi Tech Description and Major Businesses
 Table 102. Mgi Tech Product Models, Descriptions and Specifications
 Table 103. Mgi Tech Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 104. Mgi Tech Recent Developments
 Table 105. GeneMind Corporation Information
 Table 106. GeneMind Description and Major Businesses
 Table 107. GeneMind Product Models, Descriptions and Specifications
 Table 108. GeneMind Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 109. GeneMind Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Targeted Gene Sequencers Product Picture
 Figure 2. Global Targeted Gene Sequencers Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Single Carrier Product Picture
 Figure 4. Multi-Carrier Product Picture
 Figure 5. Global Targeted Gene Sequencers Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Scientific Research
 Figure 7. Clinical Medicine
 Figure 8. Agriculture
 Figure 9. Others
 Figure 10. Targeted Gene Sequencers Report Years Considered
 Figure 11. Global Targeted Gene Sequencers Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Targeted Gene Sequencers Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Targeted Gene Sequencers Revenue Market Share by Region (2020-2031)
 Figure 15. Global Targeted Gene Sequencers Sales (2020-2031) & (Units)
 Figure 16. Global Targeted Gene Sequencers Sales (CAGR) by Region (2020-2031) (Units)
 Figure 17. Global Targeted Gene Sequencers Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Targeted Gene Sequencers Sales Volume Market Share in 2024
 Figure 19. Global Targeted Gene Sequencers Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Single Carrier Revenue Market Share by Manufacturer in 2024
 Figure 22. Multi-Carrier Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Targeted Gene Sequencers Sales Market Share by Type (2020-2031)
 Figure 24. Global Targeted Gene Sequencers Revenue Market Share by Type (2020-2031)
 Figure 25. Global Targeted Gene Sequencers Sales Market Share by Application (2020-2031)
 Figure 26. Global Targeted Gene Sequencers Revenue Market Share by Application (2020-2031)
 Figure 27. North America Targeted Gene Sequencers Sales YoY (2020-2031) & (Units)
 Figure 28. North America Targeted Gene Sequencers Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Targeted Gene Sequencers Sales Revenue (US$ Million) in 2024
 Figure 30. North America Targeted Gene Sequencers Sales Volume (Units) by Type (2020- 2031)
 Figure 31. North America Targeted Gene Sequencers Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Targeted Gene Sequencers Sales Volume (Units) by Application (2020-2031)
 Figure 33. North America Targeted Gene Sequencers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Targeted Gene Sequencers Sales YoY (2020-2031) & (Units)
 Figure 38. Europe Targeted Gene Sequencers Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Targeted Gene Sequencers Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Targeted Gene Sequencers Sales Volume (Units) by Type (2020-2031)
 Figure 41. Europe Targeted Gene Sequencers Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Targeted Gene Sequencers Sales Volume (Units) by Application (2020-2031)
 Figure 43. Europe Targeted Gene Sequencers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 45. France Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Targeted Gene Sequencers Sales YoY (2020-2031) & (Units)
 Figure 50. Asia-Pacific Targeted Gene Sequencers Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Targeted Gene Sequencers Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Targeted Gene Sequencers Sales Volume (Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific Targeted Gene Sequencers Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Targeted Gene Sequencers Sales Volume (Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Targeted Gene Sequencers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 60. India Targeted Gene Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Targeted Gene Sequencers Sales YoY (2020-2031) & (Units)
 Figure 62. Central and South America Targeted Gene Sequencers Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Targeted Gene Sequencers Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Targeted Gene Sequencers Sales Volume (Units) by Type (2021-2031)
 Figure 65. Central and South America Targeted Gene Sequencers Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Targeted Gene Sequencers Sales Volume (Units) by Application (2020-2031)
 Figure 67. Central and South America Targeted Gene Sequencers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Targeted Gene Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Targeted Gene Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Targeted Gene Sequencers Sales YoY (2020-2031) & (Units)
 Figure 71. Middle East and Africa Targeted Gene Sequencers Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Targeted Gene Sequencers Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Targeted Gene Sequencers Sales Volume (Units) by Type (2021-2031)
 Figure 74. South America Targeted Gene Sequencers Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Targeted Gene Sequencers Sales Volume (Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Targeted Gene Sequencers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Targeted Gene Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Targeted Gene Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Targeted Gene Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Targeted Gene Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 81. Targeted Gene Sequencers Industry Chain Mapping
 Figure 82. Regional Targeted Gene Sequencers Manufacturing Base Distribution (%)
 Figure 83. Global Targeted Gene Sequencers Production Market Share by Region (2020-2031)
 Figure 84. Targeted Gene Sequencers Production Process
 Figure 85. Regional Targeted Gene Sequencers Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Targeted Sequencing Market Research Report 2024
Global Human Gene Sequencing Market Research Report 2024
Global Whole Genome Sequencers Market Research Report 2024
Targeted Sequencing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Sequence Testing Service Market Research Report 2024
Global All in one DNA Sequencer Market Research Report 2024
Global Personal Gene Sequencing Service Market Research Report 2025
Global Gene Chip Market Research Report 2025
Global Gene Gun Market Research Report 2024
Global Gene Microarray Chip Market Research Report 2024
Global Microarray Scanners and Sequencers Market Research Report 2024
Global Gene Knockdown Market Research Report 2025
Global DNA RNA Sequencing Kit Market Research Report 2024
Global NGS Gene Sequencing Equipment Market Research Report 2025
Global Gene Site Directed Mutagenesis Services Market Research Report 2024
Global RNA Seq Market Research Report 2024
Global Full length Transcriptome Sequencing Market Research Report 2024
Global Human Genome Sequencing Market Research Report 2024
Global Gene Service Market Research Report 2025
Global Genome Sequencing Service Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions